nach oben

Current Treatment Options in Pediatrics

Erschienen in:

01.12.2022 | Pediatric Gastroenterology (SA Saeed and E Mezoff, Section Editors)

Updates in Pediatric Cholestasis

verfasst von: Alyssa Kriegermeier, MD, Saeed Mohammad, MD

Erschienen in: Current Treatment Options in Pediatrics | Ausgabe 4/2022

Einloggen, um Zugang zu erhalten

Abstract

Purpose of Review

Cholestasis is a common disorder in pediatric hepatology with a wide variety of causative etiologies. The presentation of jaundice can be frightening. Several therapies are time sensitive, and a prompt diagnosis may improve outcomes. The purpose of this paper will be to review the etiology, diagnosis, and complications of cholestasis in children and to discuss current recommendations for the management of pediatric cholestasis.

Recent Findings

Medical management of pediatric cholestasis has traditionally been supportive, with care centered on nutrition, growth, and treatment of pruritus. The approval of new therapies for pruritus has changed the approach to disease management in certain diseases. Referral to a transplant center when there is advanced disease or significantly impaired quality of life remains important.

Summary

There are many facets to pediatric cholestasis and attention to ameliorating the complications commonly associated with them requires subspecialized care.

Harpavat S, et al. Diagnostic yield of newborn screening for biliary atresia using direct or conjugated bilirubin measurements. JAMA. 2020;323(12):1141–50.CrossRef

Gotze T, et al. Neonatal cholestasis - differential diagnoses, current diagnostic procedures, and treatment. Front Pediatr. 2015;3:43.

Hoofnagle JH. Chapter 40 - LiverTox: A website on drug-induced liver injury. In: Kaplowitz N, DeLeve LD, editors. Drug-induced liver disease (third edition). Boston: Academic Press; 2013. p. 725–32.CrossRef

Ushigome Y, et al. Short- and long-term outcomes of 34 patients with drug-induced hypersensitivity syndrome in a single institution. J Am Acad Dermatol. 2013;68(5):721–8.CrossRef

Kardaun SH, et al. Drug reaction with eosinophilia and systemic symptoms (DRESS): an original multisystem adverse drug reaction. Results from the prospective RegiSCAR study. Br J Dermatol. 2013;169(5):1071–80.CrossRef

Gura KM, et al. Fish oil emulsion reduces liver injury and liver transplantation in children with intestinal failure-associated liver disease: a multicenter integrated study. J Pediatr. 2021;230:46-54 e2.CrossRef

Heubi JE, Bove KE, Setchell KDR. Oral cholic acid is efficacious and well tolerated in patients with bile acid synthesis and Zellweger spectrum disorders. J Pediatr Gastroenterol Nutr. 2017;65(3):321–6.CrossRef

Chinsky JM, Singh R, Ficicioglu C, van Karnebeek CDM, Grompe M, Mitchell G, Waisbren SE, Gucsavas-Calikoglu M, Wasserstein MP, Coakley K, Scott CR. Diagnosis and treatment of tyrosinemia type I: a US and Canadian consensus group review and recommendations. Genet Med. 2017;19(12):1380–95. https://doi.org/10.1038/gim.2017.101.CrossRef

Welling L, et al. International clinical guideline for the management of classical galactosemia: diagnosis, treatment, and follow-up. J Inherit Metab Dis. 2017;40(2):171–6.CrossRef

10.

Taylor SA, et al. The effects of gestational alloimmune liver disease on fetal and infant morbidity and mortality. J Pediatr. 2018;196:123-128 e1.CrossRef

11.

Kriegermeier A, Green R. Pediatric cholestatic liver disease: review of bile acid metabolism and discussion of current and emerging therapies. Front Med (Lausanne). 2020;7:149.CrossRef

12.

Paumgartner G, Beuers U. Ursodeoxycholic acid in cholestatic liver disease: mechanisms of action and therapeutic use revisited. Hepatology. 2002;36(3):525–31.CrossRef

13.

Gregorio GV, et al. Effect of rifampicin in the treatment of pruritus in hepatic cholestasis. Arch Dis Child. 1993;69(1):141–3.CrossRef

14.

Jones EA, Bergasa NV. The pruritus of cholestasis and the opioid system. JAMA. 1992;268(23):3359–62.CrossRef

15.

Thornton JR, Losowsky MS. Plasma leucine enkephalin is increased in liver disease. Gut. 1989;30(10):1392–5.CrossRef

16.

Thebaut A, et al. Sertraline as an additional treatment for cholestatic pruritus in children. J Pediatr Gastroenterol Nutr. 2017;64(3):431–5.CrossRef

17.

Mayo MJ, et al. Sertraline as a first-line treatment for cholestatic pruritus. Hepatology. 2007;45(3):666–74.CrossRef

18.

Baumann U, et al. Effects of odevixibat on pruritus and bile acids in children with cholestatic liver disease: Phase 2 study. Clin Res Hepatol Gastroenterol. 2021;45(5): 101751.CrossRef

19.

Gonzales E, et al. Efficacy and safety of maralixibat treatment in patients with Alagille syndrome and cholestatic pruritus (ICONIC): a randomised phase 2 study. Lancet. 2021;398(10311):1581–92.CrossRef

20.

Sundaram SS, et al. Health related quality of life in patients with biliary atresia surviving with their native liver. J Pediatr. 2013;163(4):1052-7 e2.CrossRef

21.

Squires JE, et al. Neurodevelopmental outcomes in preschool and school aged children with biliary atresia and their native liver. J Pediatr Gastroenterol Nutr. 2020;70(1):79–86.CrossRef

Titel: Updates in Pediatric Cholestasis
verfasst von: Alyssa Kriegermeier, MD
Saeed Mohammad, MD
Publikationsdatum: 01.12.2022
Verlag: Springer International Publishing
Erschienen in: Current Treatment Options in Pediatrics / Ausgabe 4/2022
Elektronische ISSN: 2198-6088
DOI: https://doi.org/10.1007/s40746-022-00257-8

Pediatric Nausea—a Review of Current Management

Pediatric Gastroenterology (SA Saeed and E Mezoff, Section Editors)

Pediatric Overactive Bladder and the Role of Sacral Neuromodulation

Pediatric Urology (BA VanderBrink and RP Pramod, Section Editors)

Impact of Technologic Innovation and COVID-19 Pandemic on Pediatric Cardiology Telehealth

Cardiology/CT Surgery (K Gist, Section Editor)

Cardiac Arrest in Pediatric Cardiac ICUs: Prevention Comes First

Cardiology/CT Surgery (K Gist, Section Editor)

Optimization of Pediatric Antibiotic Dosing Through Therapeutic Drug Monitoring

Pediatric Infectious Disease (M Mitchell and F Zhu, Section Editors)

Point-of-Care Ultrasound-Guided Procedures in the Pediatric Cardiac Intensive Care Unit

Cardiology/CT Surgery (K Gist, Section Editor)

Kompaktes Leitlinien-Wissen Pädiatrie (Link öffnet in neuem Fenster)

Mit medbee Pocketcards schnell und sicher entscheiden.
Leitlinien-Wissen kostenlos und immer griffbereit auf ihrem Desktop, Handy oder Tablet.

Kostenlos registrieren

Neu im Fachgebiet Pädiatrie

Weniger Bargeld, weniger Erstickungsnotfälle?

16.04.2025
Pädiatrische Notfallmedizin
Nachrichten

Dadurch, dass immer seltener mit Bargeld gezahlt wird, könnte die Rate an Erstickungsnotfällen bei Kindern zurückgehen. Dieser Hypothese ist ein britisches Forschungsteam in Klinikdaten aus den letzten zweieinhalb Jahrzehnten nachgegangen.

Pneumonie ausschließen: Auf das Röntgenbild ist offenbar Verlass

15.04.2025
Pädiatrische Pneumologie
Nachrichten

Das Thoraxröntgen ist gemäß Daten aus den USA eine zuverlässige Methode, um bei Kindern in der Notaufnahme rasch eine Lungenentzündung auszuschließen. Zur Vorsicht rät das Ärzteteam jedoch bei bestimmten klinischen Symptomen.

Kawasaki-Syndrom: Kein ASS mehr in der Akutphase?

15.04.2025
Kawasaki-Syndrom
Nachrichten

Um Kinder mit Kawasaki-Syndrom vor entzündlich bedingten Veränderungen der Koronarien zu bewahren, werden sie in der Akutphase mit intravenösen Immunglobulinen und hochdosierter Acetylsalicylsäure (ASS) behandelt. Neuesten Daten zufolge könnte womöglich auf ASS verzichtet werden.

Neurologische Entwicklung von Kindern: Welchen Einfluss hat Stillen?

15.04.2025
Stillen, Säuglingsnahrung, Beikost
Nachrichten

Stillen bringt zahlreiche gesundheitliche Vorteile mit sich. Ob dazu auch ein niedrigeres Risiko für Entwicklungsverzögerungen und -störungen gehört, hat nun eine israelische Studie untersucht.

Update Pädiatrie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Springer Medizin

Updates in Pediatric Cholestasis